Brain MRI Imaging Changes & Associated Factors on Cognition Function in

Status Recruiting

Clinical Trial Summary

The purpose of this study is to investigate the brain MRI imaging changes and associated factors on cognition function in patients with premature ovarian failure.

Clinical Trial Description

Premature Ovarian Failure (POF) refers to a disease characterized by amenorrhea, infertility, low estrogen levels, and high gonadotropin concentration in women before the age of 40. In recent years, the incidence has shown a significant increase. The average age of POF in China is 28.9 years old, involving 2 million women of childbearing age. POF patients have significant emotional disorders and cognitive changes, but it is not known whether the structure and function of the POF patients' brain have changed. It is known that the perimenopause (i.e. estrogen decline) may be the early stage of AD. Therefore, this study aims to use brain imaging technology to explore the changes of brain injury in POF patients with the progression of the disease to achieve early assessment of AD in POF patients. The research work of this project is mainly based on multimodal magnetic resonance imaging technology. For the clinical phenomenon of brain dysfunction in POF patients, it analyzes the changes in brain structure and brain function of POF patients for the first time. Using artificial intelligence brain network analysis method, from the perspective of brain structure and brain function, to determine whether there is microstructural transformation of white matter in POF patients and whether it is related to disease progression and serological indicators. Through the implementation of this project, it provides a basis for brain structure and functional changes for the diagnosis and treatment of POF, and provides a basis for large-scale clinical research to guide clinical formulation of reasonable diagnosis and treatment plans and prognosis evaluation. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06121388
Study type	Observational
Source	International Peace Maternity and Child Health Hospital
Contact	Dongmei Lai, M.D.
Phone	86-021-64070434
Email	laidongmei@hotmail.com
Status	Recruiting
Phase
Start date	January 1, 2023
Completion date	December 31, 2025

View Details

See also
Status	Clinical Trial	Phase
Unknown status	`NCT01853501` - Effects of ADSC Therapy in Women With POF	Phase 4
Completed	`NCT00417066` - Flexible GnRH Antagonist vs Flare up GnRH Agonist Protocol in Poor Responders	Phase 4
Active, not recruiting	`NCT04675970` - Long Term Follow up Patients With Premature Ovarian Failure ex Vivo Gene Therapy
Recruiting	`NCT03480412` - Second Step Protocol in Poor Ovarian Responder (POR)
Completed	`NCT02644447` - Transplantation of HUC-MSCs With Injectable Collagen Scaffold for POF	Phase 1/Phase 2
Completed	`NCT03840824` - Blood Spot Self-administered Test and Assay
Recruiting	`NCT00119925` - 'SPRING'-Study: "Subfertility Guidelines: Patient Related Implementation in the Netherlands Among Gynaecologists"	N/A
Recruiting	`NCT06117982` - The Impact of Granulocyte Colony Stimulating Factor on Premature Ovarian Insufficiency	Phase 2
Suspended	`NCT03816852` - The Safety and Efficiency Study of Mesenchymal Stem Cell (19#iSCLife®-POI) in Premature Ovarian Insufficiency	Phase 2
Not yet recruiting	`NCT04390308` - Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation?
Completed	`NCT02783937` - Filgrastim for Premature Ovarian Insufficiency	Phase 4
Completed	`NCT00295087` - X-Chromosome Inactivation Status and Premature Ovarian Failure	N/A
Completed	`NCT00429494` - GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients	Phase 2
Not yet recruiting	`NCT05522634` - A Clinical Study of Chinese Herbal Compound TJAOA101 in the Treatment of Premature Ovarian Insufficiency	Early Phase 1
Recruiting	`NCT05838157` - The Effect of HPV Vaccine on Menstrual Cycle in Women of Reproductive Age
Withdrawn	`NCT01129947` - The Use of DHEA in Women With Premature Ovarian Failure	Phase 0
Completed	`NCT00001275` - Ovarian Follicle Function in Patients With Primary Ovarian Failure	N/A
Not yet recruiting	`NCT04306185` - Ovarian Fragmentation Study (Crespo Medical Team)	N/A
Recruiting	`NCT02062931` - Autologous Mesenchymal Stem Cells Transplantation In Women With Premature Ovarian Failure	Phase 1/Phase 2
Completed	`NCT02151890` - Pregnancy After Stem Cell Transplantation in Premature Ovarian Failure	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Brain MRI Imaging Changes and Associated Factors on Cognition Function in Patients With Premature Ovarian Failure

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms